To note, the score included HER2 expression, which is not routinely measured for DCIS, and the positive triplet of P16, COX-2, and KI-67, whose association with invasive LRs was previously described by Kerlokinske et al. [118]. Here, ERBB2 is linked to ductal breast carcinoma in situ.